Amazon Health Chief Neil Lindsay to Step Down July 1, Replaced by Amwell Co-Founder Roy Schoenberg
- Sara Montes de Oca

- 2 hours ago
- 2 min read
Amazon's senior vice president of Amazon Health Services, Neil Lindsay, will step down from his role on July 1, the company announced Wednesday, marking the latest in a series of leadership changes inside its health-care division.
Dr. Roy Schoenberg, a co-founder of telemedicine provider Amwell, will succeed Lindsay, according to a memo posted to Amazon's website by Doug Herrington, the company's worldwide retail chief.
Lindsay, who joined Amazon more than 15 years ago, has led Amazon Health Services since 2021. The unit encompasses Amazon Pharmacy, primary care chain One Medical, and a range of other health-related initiatives. He will remain at the company in an advisory capacity through the end of the year and plans to continue advising health-care technology companies thereafter.
Herrington described Schoenberg as bringing "a rare combination of clinical expertise, technology vision, and experience building health-care businesses at scale."
In a separate internal memo, Lindsay said he had taken on the role specifically to recruit clinicians, operators, technologists, and leaders who understood health care deeply. "Now is the right time to step back and pass the baton to a leader who knows how to navigate the next phase of this journey better than I," Lindsay wrote. "I'm excited to do so."
The transition underscores the challenges Amazon has faced in its long-running effort to establish a significant presence in the U.S. health-care market, a sector the company has described as complex and inefficient.
Amazon's first major move in health care came in 2018 with the acquisition of online pharmacy PillPack for approximately $750 million, which formed the foundation for Amazon Pharmacy. The company then acquired primary care chain One Medical for $3.9 billion in 2023, one of its largest deals on record, gaining access to a network of brick-and-mortar clinics and a sizable membership base.
The company has also launched and discontinued a telehealth service, wound down its Halo health and fitness wearable line as part of broader cost-cutting measures, and, earlier this year, introduced an artificial intelligence tool capable of analyzing medical records, booking appointments, and responding to patient queries.
Lindsay's departure is not an isolated shake-up. One Medical's chief executive left in March of last year, Amazon's chief medical officer departed last May, and the company's VP of health care exited in December to join Humana.
Schoenberg's appointment brings a health-care-native perspective to the division's top role — a deliberate contrast to Lindsay, who previously led Amazon's Prime subscription service and managed worldwide marketing for its consumer devices before taking on AHS.
Whether Schoenberg's clinical and entrepreneurial background accelerates Amazon's ambitions in a sector that has resisted easy disruption remains the central question for the unit heading into the second half of 2026.


